27.01.2011
- Sanofi-Aventis has made progress in talks with U.S. bid target Genzyme and leaders of both companies may bump into each other in Davos this week, Sanofi's CEO said on Wednesday...
24.01.2011
- French drugmaker Sanofi-Aventis extended its snubbed $18.5 billion tender offer for U.S. biotech Genzyme for a second time as the companies continue behind-the-scenes talks to...
21.01.2011
- Genzyme which has struggled with manufacturing problems of its top products, said it would expand operations in Geel, Belgium, to support its drugs for Pompe disease. Genzyme...
20.01.2011
- French drugmaker Sanofi-Aventis is likely to extend its $18.5 billion tender offer for Genzyme one last time as it seeks to buy the U.S. maker of drugs for rare diseases, sources...
14.01.2011
- French drugmaker Sanofi-Aventis hopes to reach a takeover deal that would value U.S. target Genzyme at around $76 per share, or some $20 billion, the French daily newspaper Le...
13.01.2011
- French drugmaker Sanofi-Aventis won European Union regulatory approval on Wednesday for its hostile $18.5 billion takeover bid for U.S. biotech firm Genzyme. The European...
12.01.2011
- Genzyme, the subject of an $18.5 billion hostile takeover bid from Sanofi-Aventis SA, posted preliminary Q4 earnings that fell short of Wall Street forecasts and cut its earnings...
11.01.2011
- Genzyme acknowledged on Monday that it was discussing a takeover deal with French drugmaker Sanofi-Aventis, but hopes for a quick agreement cooled as both sides noted differences...
